Pfizer and BioNTech Advance Next-Generation COVID-19 Vaccine Strategy with Study Start of Candidate Aimed at Enhancing Breadth of T cell Responses and Duration of Protection
BioNTech SENEW YORK and MAINZ, GERMANY, NOVEMBER 16, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today...

COVID-19 and myocarditis in competitive athletes | Medical News Bulletin
Quick takes: Climate change impact, dengue in Bangladesh, hypervirulent recombinant coronavirus in cats
After-action report finds that hepatitis A outbreak helped hone COVID-19 response – The San Diego Union-Tribune
Ohio could drop below lowest COVID-19 cases in a year – NBC4 WCMH-TV
The Search for Long Covid Treatments Takes a Promising Turn – WIRED